Covered recipient · General Payments record
TAL J RUBINSTEIN
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$5,529.04
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $246.00 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $223.76 | 18 |
| Kerecis Limited | $22.24 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $32.82 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072094 | CMS |
| Amgen Inc. | $2.93 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072081 | CMS |
| Amgen Inc. | $7.18 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072087 | CMS |
| Amgen Inc. | $25.53 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072101 | CMS |
| Amgen Inc. | $31.70 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072107 | CMS |
| Amgen Inc. | $6.32 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072115 | CMS |
| Amgen Inc. | $5.79 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072127 | CMS |
| Amgen Inc. | $12.43 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072121 | CMS |
| Amgen Inc. | $3.48 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072133 | CMS |
| Amgen Inc. | $0.44 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072141 | CMS |
| Amgen Inc. | $6.65 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072147 | CMS |
| Amgen Inc. | $10.11 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072154 | CMS |
| Amgen Inc. | $9.19 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072161 | CMS |
| Amgen Inc. | $5.72 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072167 | CMS |
| Amgen Inc. | $16.73 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072174 | CMS |
| Amgen Inc. | $12.95 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072181 | CMS |
| Amgen Inc. | $18.66 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072188 | CMS |
| Amgen Inc. | $15.13 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116072194 | CMS |
| Kerecis Limited | $22.24 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120101165 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.